Operating Income for Incyte (INCY)
According to Incyte's latest reported financial statements, the company's current operating income (TTM) is $1.44B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
INCY
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$1.44B
YoY change
+1575.4%
5Y CAGR
N/A
Peak year (2025)
$1.34B
Cumulative operating income
$2.41B
Operating Income history chart for Incyte (INCY) from 1993 to 2025
Operating Income history table for Incyte (INCY) from 1993 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $1.34B | +1575.4% | ||
| 2024 | $80.14M | -87.7% | ||
| 2023 | $651.77M | +8.7% | ||
| 2022 | $599.56M | -6.0% | ||
| 2021 | $637.54M | -365.3% | ||
| 2020 | -$240.29M | -157.0% | ||
| 2019 | $421.69M | +171.4% | ||
| 2018 | $155.40M | -165.9% | ||
| 2017 | -$235.68M | -243.7% | ||
| 2016 | $164.02M | +223.8% | ||
| 2015 | $50.65M | -1154.4% | ||
| 2014 | -$4.80M | -70.2% | ||
| 2013 | -$16.10M | -1502.6% | ||
| 2012 | $1.15M | -100.8% | ||
| 2011 | -$142.47M | -1142.2% | ||
| 2010 | $13.67M | -109.9% | ||
| 2009 | -$137.76M | -13.6% | ||
| 2008 | -$159.52M | +86.6% | ||
| 2007 | -$85.48M | +15.6% | ||
| 2006 | -$73.96M | -25.6% | ||
| 2005 | -$99.43M | +1.7% | ||
| 2004 | -$97.77M | -34.5% | ||
| 2003 | -$149.30M | +52.5% | ||
| 2002 | -$97.91M | +51.3% | ||
| 2001 | -$64.70M | +3.4% | ||
| 2000 | -$62.59M | +131.8% | ||
| 1999 | -$27.00M | -321.3% | ||
| 1998 | $12.20M | +64.9% | ||
| 1997 | $7.40M | -225.4% | ||
| 1996 | -$5.90M | -46.4% | ||
| 1995 | -$11.00M | -9.1% | ||
| 1994 | -$12.10M | +146.9% | ||
| 1993 | -$4.90M | — |
Operating Income values are taken from Incyte's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Incyte (INCY) reported operating income of $1.34B – surged 1575.4% year-over-year.
Over 2015–2025 (10 years), Incyte operating income expanded at a +38.8% compound annual rate, with the latest reading among the more recent periods of the dataset.
2025 marks the peak operating income at $1.34B, with the historical low of -$240.29M recorded in 2020.
Among 8 Healthcare peers, Incyte (INCY) ranks 9th; the peer median for operating income is $22.84B.
Incyte Operating Income by Year
Incyte Operating Income 2025: $1.34B
Incyte operating income in 2025 was $1.34B, surged 1575.4% from 2024. This figure represents the highest annual value in the available history.
Incyte Operating Income 2024: $80.14M
Incyte operating income in 2024 was $80.14M, plunged 87.7% below 2023.
Incyte Operating Income 2023: $651.77M
Incyte operating income in 2023 was $651.77M, grew 8.7% from 2022.
Incyte Operating Income 2022: $599.56M
Incyte operating income in 2022 was $599.56M, declined 6.0% below 2021.
Incyte Operating Income 2021: $637.54M
Incyte operating income in 2021 was $637.54M.
See more financial history for Incyte (INCY).
Sector peers — Operating Income
Companies in the same sector as Incyte, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Incyte's operating income?
- Latest reported operating income for Incyte (INCY) is $1.44B (period ending March 31, 2026).
How has Incyte operating income changed year-over-year?
- Incyte (INCY) operating income changed +1575.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Incyte operating income?
- Incyte (INCY) operating income compound annual growth rate is +38.8% over the most recent 10 years available.
When did Incyte operating income hit its highest annual value?
- Incyte operating income reached its highest annual value of $1.34B in 2025.
What was Incyte operating income in 2024?
- Incyte (INCY) operating income in 2024 was $80.14M.
What was Incyte operating income in 2025?
- Incyte (INCY) operating income in 2025 was $1.34B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INCY Overview
Company profile, financial tools, and key metrics
INCY Revenue Counter
Earns $163.03 every second. See per minute, hour, and day.
INCY Earnings Counter
Earns $40.80 per second net profit. See per minute, hour, and day.
INCY Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
INCY What If Invested
What if you had invested $1,000? See historical returns from any date.
INCY How It Makes Money
Discover visual breakdown of $5.14B in revenue — where it comes from and where it goes.
INCY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INCY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INCY Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
INCY Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
INCY Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.